Discontinued — last reported Q4 '25
DexCom Unrealized Gains on Investments decreased by 81.3% to $300.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 75.0%, from $1.20M to $300.00K. Over 4 years (FY 2020 to FY 2025), Unrealized Gains on Investments shows an upward trend with a 68.2% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates favorable market conditions for the company's investment portfolio, enhancing the overall book value of the firm.
This represents the positive difference between the current market value and the amortized cost of available-for-sale in...
Reflects market-wide interest rate and credit spread environments; comparable across all firms with large investment portfolios.
unrealized_gains_on_investments| Q2 '21 | Q3 '21 | Q4 '22 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $100.00K | $0.00 | $200.00K | $600.00K | $500.00K | $1.30M | $400.00K | $100.00K | $3.80M | $1.70M | $1.20M | $800.00K | $1.80M | $1.60M | $300.00K |
| QoQ Change | — | -100.0% | — | +200.0% | -16.7% | +160.0% | -69.2% | -75.0% | >999% | -55.3% | -29.4% | -33.3% | +125.0% | -11.1% | -81.3% |
| YoY Change | — | — | — | — | — | +550.0% | — | -83.3% | +660.0% | +30.8% | +200.0% | +700.0% | -52.6% | -5.9% | -75.0% |